11/12/2026
We are among the first in Michigan to offer an innovative liver cancer treatment called histotripsy – and our patient Brenda Broome was the first at Henry Ford Health to experience it.
Brenda had been living with liver disease for almost a decade before being diagnosed with liver cancer last year. She wasn’t able to undergo surgery due to her liver disease, but she was a candidate for histotripsy – a non-invasive, FDA-approved procedure that uses ultrasound waves to create tiny bubbles within tumors that destroy cancer cells.
“In Brenda's case, we were able to successfully treat and destroy her liver cancer while avoiding the risks associated with surgery,” says Dr. Nik Kolicaj, our division chief of vascular and interventional radiology at Henry Ford Health. “One of the greatest advantages of this technology is that patients can undergo treatment on an outpatient basis and return home the same day. Seeing Brenda do so well has been incredibly rewarding and highlights the promise of this groundbreaking therapy for patients with liver cancer.”
Brenda has been so encouraged by her experience that she has shared it with others, including her brother, who later underwent histotripsy for prostate cancer. Brenda’s daughter, Michele Robbins, says the procedure gave her family renewed hope.
“From our perspective, the procedure was fabulous, making a major difference in my mom’s life,” Michele says. “So far there is no evidence of liver tumors and she tolerated the procedure really well. We are not only pleased with the outcome, but also the great communication from Dr. Kolicaj and the Henry Ford team. They treated my mom like family, which is what any family hopes for when undergoing treatment.”
Read Brenda’s full story: https://bit.ly/4jbDymh